Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota.

about

Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis.

P2860

Q55498067-0270585B-6115-48E9-8873-44636C12090D

P2860

Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota.

Item

http://www.wikidata.org/entity/Q36181782

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota.

@ast

Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota.

@en

type

Item

label

Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota.

@ast

Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota.

@en

prefLabel

Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota.

@ast

Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota.

@en

P1476

Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota

@en

P2093

Andrea Minuti

http://www.w3.org/2001/XMLSchema#string

Annalisa Rebecchi

http://www.w3.org/2001/XMLSchema#string

Eugenia Bruzzese

http://www.w3.org/2001/XMLSchema#string

Francesco Miragoli

http://www.w3.org/2001/XMLSchema#string

Maria Luisa Callegari

http://www.w3.org/2001/XMLSchema#string

Susanna Ferrari

http://www.w3.org/2001/XMLSchema#string

Vittoria Buccigrossi

http://www.w3.org/2001/XMLSchema#string

P2860

A human gut microbial gene catalogue established by metagenomic sequencing

Hydrogen Sulfide in Physiology and Diseases of the Digestive Tract

Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon

Mechanisms of microbial hydrogen disposal in the human colon and implications for health and disease

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

New bacterial species associated with chronic periodontitis.

Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria.

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.

Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.

P31

scholarly article

P356

10.1093/FEMSEC/FIW230

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sara Federici

Alfredo Guarino

P577

2016-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27810876

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

5155554

http://www.w3.org/2001/XMLSchema#string

Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota.

about

P2860

P2860

Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932